Philippines Food and Drug Administration promotes generics medicine

19 September 2013

The Philippines Department of Health Foods and Drugs Administration (PFDA) today (September 19) launched the Generics Awareness Month celebration with the theme “Generics Pangkalusugan, Gamot Pangkalahatan” (Health, General Medicine).

Sonia Cabahit, head of the PFDA, said that the month-long celebration aims to raise public awareness on generic drugs, which are more affordable but safe and quality medicines.

Dr Cabahit added that the celebration also reminds medical professionals and businesses, especially government hospitals, to abide by the Generics Law or RA 9502 which mandates government and all those employed by the government such as retained hospitals and its medical practitioners the use of generic terminologies in transactions relating to prescribing, dispensing and administering medicines to patients.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Generics